Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Blueprint Medicines Corp 45 SIDNEY STREET CAMBRIDGE MA 02139 USA

www.blueprintmedicines.com Employees: 649 P: 617-374-7580

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Blueprint Medicines Corporation is a biopharmaceutical company focused on developing the potentially transformational precision medicines to address patients with genomically defined cancers and rare diseases.

Key Statistics

Overview:

Market Capitalization, $K 8,360,786
Enterprise Value, $K 8,645,746
Shares Outstanding, K 64,582
Annual Sales, $ 508,820 K
Annual Net Income, $ -67,090 K
Last Quarter Sales, $ 149,410 K
Last Quarter Net Income, $ 500 K
EBIT, $ -174,310 K
EBITDA, $ -180,480 K
60-Month Beta 0.89
% of Insider Shareholders 4.21%
Float, K 61,863
% Float 95.79%
Short Volume Ratio 0.20

Growth:

1-Year Return 13.20%
3-Year Return 149.54%
5-Year Return 73.38%
5-Year Revenue Growth 665.03%
5-Year Earnings Growth 47.87%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.74 on 05/01/25
Next Earnings Date 08/07/25
Earnings Per Share ttm -3.22
EPS Growth vs. Prev Qtr 6.33%
EPS Growth vs. Prev Year 43.94%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BPMC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -64.60%
Return-on-Assets % -17.22%
Profit Margin % -13.19%
Debt/Equity 1.13
Price/Sales 16.41
Price/Cash Flow N/A
Price/Book 24.40
Book Value/Share 5.30
Interest Coverage -1.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar